Dr. Beaula V. Koduri, MD

  • Union, NJ
  • Hematologist and oncologist
NPI1972505311PAC ID9032189105
Medicare services, 2024
87,783
Medicare patients, 2024
482
Part D claims, 2024
529
MIPS score, 2024
100
Hospital affiliations
1
Practice address
485 Chestnut St, Union, NJ 07083
Practice phone
Call (732) 483-4501
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Hematology Oncology Consultants

Union, New Jersey

See all 4 affiliations

Find Dr. Koduri's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Beaula V. Koduri is a hematologist and oncologist in Union, New Jersey

Dr. Koduri practices at Hematology Oncology Consultants in Union, New Jersey.

Dr. Koduri's NPI, 1972505311, was assigned on August 15, 2005. Dr. Koduri holds New Jersey license 25MA08158600.

NPI and contact details
Medicare PAC ID
9032189105
NPI enumeration date
August 15, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(732) 483-4501
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Beaula V. Koduri practices at Hematology Oncology Consultants in Union, New Jersey

Dr. Koduri's primary practice is Hematology Oncology Consultants, at 485 Chestnut St, Union, NJ 07083 in Union County. The practice phone is (732) 483-4501.

  • Hematology Oncology Consultants
    485 Chestnut St, Union, NJ 07083 · Union CountyPhone(732) 483-4501

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Beaula V. Koduri is affiliated with 3 sites of care and 1 medical group

Dr. Koduri's primary practice is Hematology Oncology Consultants in Union, New Jersey. Dr. Koduri is also affiliated with JFK University Medical Center. The medical group on file is Hematology Oncology Care of New Jersey (HOC). Dmand AI also links Dr. Koduri to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Koduri

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Beaula V. Koduri's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koduri practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Hematology Oncology ConsultantsAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Koduri practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Beaula V. Koduri is one of 364 hematologists and oncologists in New Jersey

Hematology and oncology is Dr. Koduri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Koduri is licensed in New Jersey.

Specialties and state licenses

  • Hematology and oncology, New JerseyPrimaryLicense 25MA08158600 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Koduri

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

364hematologists and oncologists in New Jersey
2hematologists and oncologists in Union

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Beaula V. Koduri billed Medicare for 87,783 services in 2024

CMS data shows 87,783 Medicare services from Dr. Koduri across 24 procedure codes in 2024, for 482 Medicare patients. Medicare paid $359,209 for them.

Medicare services, 202487,783
Medicare patients482
Paid by Medicare$359,209
Procedure codes24

Dr. Koduri's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 189,7992024: 79,74858%
Surgery
2023: 2,6642024: 2,29314%
Office and hospital visits
2023: 2,5612024: 2,17015%
Tests and treatments
2023: 2,5642024: 1,82429%
Lab and pathology
2023: 2,1482024: 1,74819%

Where Dr. Koduri's Medicare services took place, 2024

  • In an office87,682100%
  • In a facility1010%

Dr. Koduri compared with the New Jersey median for hematologists and oncologists, 2024

  • Dr. Koduri
  • New Jersey median
Medicare services
87,783vs 1,51557.9 times
Medicare patients
482vs 33743% above
Part D claims
349vs 3788% below

Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. Koduri's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Koduri

Need commercial claims for Dr. Koduri?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Koduri and other hematologists and oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Beaula V. Koduri treated 482 Medicare patients in 2024, average age 75

CMS counts 482 Medicare patients who saw Dr. Koduri in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koduri's median patient age at 62, with 69% women.

Medicare patients, 2024482
Average age75
Average risk score1.85
Also on Medicaid38%

Dr. Koduri's Medicare patients by age, 2024

Dr. Koduri's Medicare patients by sex, 2024

  • Women30062%
  • Men18238%

Chronic conditions among Dr. Koduri's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes60%
  4. Arthritis51%
  5. Ischemic heart disease42%
  6. Chronic kidney disease35%
  7. Cancer28%
  8. Anxiety24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Koduri's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 62

Patient panel by sex, all payers

  • Women69%
  • Men28%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Beaula V. Koduri wrote 529 Medicare Part D claims in 2024

In 2024, Dr. Koduri wrote 529 Medicare Part D claims for 138 patients. 58% of them were for generic drugs. CMS names the drug for 349 of them, across 12 drugs with 11 or more claims each, at $469,640 in total drug cost. In 2023, CMS named 358 claims across 10 drugs.

Part D claims, 2024529
Drugs named by CMS12
Total drug cost$469,640
Part D patients138

Dr. Koduri's Part D claims by kind of drug, 2024

  • Generic307 claims58%
  • Brand-name222 claims42%

Dr. Koduri's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Koduri's Part D claims, 2024

  • Antibiotics2%11 of 529 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3582024: 3493%

Drugs named by CMS: 12 in 2024, 10 in 2023.

See all prescribing by Dr. Koduri

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Beaula V. Koduri scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Koduri for performance year 2024, reported individually. Dr. Koduri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Koduri's MIPS scores, performance year 2024

  • 100of 100Final score
  • 97.6of 100Quality
  • 97of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Koduri by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Beaula V. Koduri received $19,972 in industry payments from 2016 to 2025

CMS Open Payments shows 1,145 general payments to Dr. Koduri from 79 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Bristol-Myers Squibb Company paid the most, $2,159.

General payments to Dr. Koduri by program year, 2016 to 2025

General payments to Dr. Koduri by kind, 2016 to 2025

$20Kin total
  • Food and beverage$18,29392%
  • Education$1,6798%

Companies that paid Dr. Koduri the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Koduri

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Beaula V. Koduri's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Beaula V. Koduri

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Beaula V. Koduri's NPI number?

Dr. Beaula V. Koduri's NPI number is 1972505311. It was assigned on August 15, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Beaula V. Koduri?

Dr. Beaula V. Koduri is a hematologist and oncologist in Union, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Beaula V. Koduri practice?

Dr. Koduri practices at 485 Chestnut St, Union, NJ 07083. Dr. Koduri's primary practice is Hematology Oncology Consultants in Union, New Jersey. Dmand AI also links Dr. Koduri to 1 group practice or clinic.

What is Dr. Beaula V. Koduri's office phone number?

The practice phone on file for Dr. Koduri is (732) 483-4501.

What is Dr. Beaula V. Koduri's medical license number?

Dr. Koduri holds New Jersey license 25MA08158600.

Which hospitals is Dr. Beaula V. Koduri affiliated with?

Dr. Koduri is affiliated with JFK University Medical Center.

What medical group is Dr. Beaula V. Koduri part of?

Dr. Koduri is linked to Hematology Oncology Care of New Jersey (HOC).

Does Dr. Beaula V. Koduri accept Medicare?

Yes. CMS data shows Dr. Koduri billed Medicare for 87,783 services in 2024, and Dr. Koduri accepts Medicare assignment.

What is Dr. Beaula V. Koduri's MIPS score?

Dr. Koduri's MIPS final score for performance year 2024 is 100 out of 100, reported individually.

How many Medicare patients does Dr. Beaula V. Koduri see?

CMS counts 482 Medicare patients who saw Dr. Koduri in 2024, with an average age of 75.

Show 4 more questionsShow fewer questions

What services does Dr. Beaula V. Koduri bill to Medicare?

In 2024, Dr. Koduri's most billed Medicare services were injected or infused drug (J1756), injected or infused drug (J0885) and injected or infused drug (J2916).

What drugs does Dr. Beaula V. Koduri prescribe most?

In 2024 Medicare Part D data, Dr. Koduri's most prescribed drugs by claims were Anastrozole, Eliquis and Hydroxyurea.

Has Dr. Beaula V. Koduri received payments from drug or device companies?

CMS Open Payments shows $19,972 in general payments to Dr. Koduri from 79 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Beaula V. Koduri been practicing?

Dr. Koduri graduated from medical school in 1995, 31 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)